Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Coach, Inc. (COH) Jumps On Q4 Beat; Hedge Funds Were Bearish

Page 1 of 2

Despite a sales decline, Coach, Inc. (NYSE:COH) managed to beat the Street’s expectations for its fiscal fourth quarter ended June 27, boosting its stock by nearly 7% in early trading today. The luxury accessories design house posted today a net income of $11.7 million, or $0.04 per share, down from $75.2 million, or $0.27 per share in the year-ago quarter, on revenues of $1 billion, below the $1.14 billion sales the firm reported in the same quarter last year. Earnings adjusted for non-recurring costs and expenses related to mergers and acquisitions was reported to be $0.31 per share, down from $0.59 per share in the prior-year quarter. These figures for the fiscal fourth quarter of the firm beat consensus estimates of $0.29 per share on revenues of $973 million, even as they are weighed down by a 19% drop in same-store sales and an overall 20% fall in sales in North America.

For the whole fiscal year 2015, Coach, Inc. (NYSE:COH) posted earnings of $402.4 million, or $1.45 per diluted share on revenues of $4.19 billion, down from $781 million, or $2.79 per diluted share, on revenues of $4.81 billion in the last fiscal year. The designer handbag maker’s board has declared a quarterly cash dividend of $0.3375 per common share. The spike in Coach’s share price today is welcome news for the company as it saw its stock decline by over 15% year-to-date.

Coach Inc. (COH), NYSE:COH, Yahoo Finance,

It should be noted, however, that hedge funds were bearish on Coach in the first quarter. By the end of March, a total of 36 of the hedge funds tracked by Insider Monkey were long on this stock at the end of March, down from 39 in the preceding quarter. Total value of holdings also decreased by 21.43% on the quarter to $374.42 million. This decline is magnified by the fact that the stock climbed by over 10% in that said period, which shows that the company saw an outflow of investors’ money.

General opinion is that hedge funds underperform the S&P500 based on net returns. But we are missing something very important here. Hedge funds generally pull in strong returns from their top small-cap stocks and invest a lot of their resources into analyzing these stocks. They simply don’t take large enough positions in them relative to their portfolios to generate strong overall returns because their large-cap picks underperform the market. We share the top 15 small-cap stocks favored by the best hedge fund managers every quarter and this strategy has managed to outperform the S&P500 every year since it was launched in August 2012, returning 123.1% and beating the market by 66.5 percentage points (read more details). Because of this, we know that collective hedge fund sentiment is extremely telling and valuable.

We also track insider trading surrounding companies such as Coach, Inc. (NYSE:COH) to see whether insiders are confident about the companies’ performance. While there have been no purchases among Coach’s insiders, there have been several sales. At the beginning of March, Global Human Resources Officer Sarah Dunn sold 4,000 shares. Meanwhile, Global Corporate Affairs Officer Todd Kahn sold a total of 7,667 shares in two transactions towards the end of February. Keeping these in mind, let’s take a glance at the recent hedge fund activity surrounding Coach, Inc.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!